Nuvation Bio
Amy Muse has extensive experience in the biopharmaceutical industry, currently serving as Vice President of Commercial Operations and Strategic Insights at Nuvation Bio. Prior to this role, Amy held the position of Vice President of Commercial Strategy at AnHeart Therapeutics, which was acquired by Nuvation Bio. Additionally, Amy was Vice President of Marketing at Seres Therapeutics and held various leadership positions at Takeda Oncology, where responsibilities included US Franchise Lead for the Lung Portfolio and US Brand Lead for ALUNBRIG. Earlier at Takeda, roles included Senior Marketing Director for US Immunology and Global Marketing Director for Global Immunology Launch Lead.
This person is not in any teams
This person is not in any offices
Nuvation Bio
2 followers
Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.